Canada
· Delayed Price · Currency is CAD Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of CAD 8.26 million. The enterprise value is 8.14 million.
| Market Cap | 8.26M |
| Enterprise Value | 8.14M |
Important Dates
The last earnings date was Monday, March 31, 2025.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +26.48% |
| Shares Change (QoQ) | +2.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 92.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.40 |
| PB Ratio | 4.73 |
| P/TBV Ratio | 6.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.64 |
| EV / Sales | 13.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.48 |
Financial Position
The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.15.
| Current Ratio | 0.44 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | -15.78 |
Financial Efficiency
Return on equity (ROE) is -234.51% and return on invested capital (ROIC) is -79.02%.
| Return on Equity (ROE) | -234.51% |
| Return on Assets (ROA) | -52.40% |
| Return on Invested Capital (ROIC) | -79.02% |
| Return on Capital Employed (ROCE) | -202.13% |
| Revenue Per Employee | 47,437 |
| Profits Per Employee | -382,329 |
| Employee Count | 13 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.00% in the last 52 weeks. The beta is 1.05, so Filament Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -40.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 56.01 |
| Average Volume (20 Days) | 16,922,274 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, Filament Health had revenue of CAD 616,678 and -4.97 million in losses. Loss per share was -0.02.
| Revenue | 616,678 |
| Gross Profit | 616,678 |
| Operating Income | -3.77M |
| Pretax Income | -4.97M |
| Net Income | -4.97M |
| EBITDA | -3.69M |
| EBIT | -3.77M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 391,237 in cash and 264,502 in debt, giving a net cash position of 126,735.
| Cash & Cash Equivalents | 391,237 |
| Total Debt | 264,502 |
| Net Cash | 126,735 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.75M |
| Book Value Per Share | 0.01 |
| Working Capital | -859,508 |
Cash Flow
In the last 12 months, operating cash flow was -2.29 million and capital expenditures -50,478, giving a free cash flow of -2.34 million.
| Operating Cash Flow | -2.29M |
| Capital Expenditures | -50,478 |
| Free Cash Flow | -2.34M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -610.99% |
| Pretax Margin | -805.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.48% |
| Shareholder Yield | -26.48% |
| Earnings Yield | -60.17% |
| FCF Yield | -28.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Filament Health has an Altman Z-Score of -13.85. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.85 |
| Piotroski F-Score | n/a |